Beijing Huaguan Biotechnology Co., Ltd. was founded in 2018 and is headquartered in Haidian District, Beijing。At present, it has four R & D centers in Beijing, Nanjing, Chongqing and Suzhou with a total area of nearly 10,000 square meters, with perfect R & D capabilities and R & D quality assurance system。The company's GMP production base for apis is located in Ulanqab City, Inner Mongolia, 2 hours' drive from Beijing, with a total area of 140 mu, which meets the production, quality control and environmental protection requirements of GMP apis and non-GMP key starting materials。The total number of employees of the company is nearly 300, including 100 research and development scientists。Relying on years of technology and experience accumulation, the company has established three technology platforms, which are one arrow multi-star ADC innovative drug platform, complex molecular synthesis technology platform, continuous flow technology platform and enzyme catalysis technology platform。The company provides customers with innovative drugs, generic drugs, major health products related material supply, as well as drug research and development registration and application technical services, covering the full life cycle of drugs from pre-clinical to post-marketing。